← Back to catalogue

Carolina Liquid Chemistries Corp.® Ldl Cholesterol Direct Reagent Kit St661

FDA UDI

Class I (US FDA UDI)

by Carolina Liquid Chemistries Corp.

Identity

Trade Name
CAROLINA LIQUID CHEMISTRIES CORP.® LDL CHOLESTEROL DIRECT REAGENT KIT ST661 FDA UDI
Generic Name
Low density lipoprotein (LDL) cholesterol IVD, kit, spectrophotometry FDA UDI
Device Name
LDL Cholesterol Reagent (LDL) w/ Calibrator FDA UDI
Model / Reference
ST661 FDA UDI
Description
LDL Cholesterol Reagent (LDL) w/ Calibrator FDA UDI

Identifiers

Catalog Number
ST661 FDA UDI
Primary DI / UDI-DI
00817302024623 FDA UDI
FDA Product Code
MRR FDA UDI
GMDN Term
Low density lipoprotein (LDL) cholesterol IVD, kit, spectrophotometry FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1475 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 3 Milliliter FDA UDI
Total Volume — 44 Milliliter FDA UDI
Total Volume — 16 Milliliter FDA UDI

Category: Low density lipoprotein (LDL) cholesterol IVD, kit, spectrophotometry

Carolina Liquid Chemistries Corp.® Ldl Cholesterol Direct Reagent Kit St661 by Carolina Liquid Chemistries Corp. — Class I — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as Low density lipoprotein (LDL) cholesterol IVD, kit, spectrophotometry.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 4e64ba6c-579a-41b8-a737-79ef5b695d6d 37 fields · synced May 30, 2026